Oragenics Inc.
13700 Progress Boulevard
Alachua,
FL 32615
United States - Map
Phone: 386-418-4018
Fax: 386-418-1660
Web Site: http://www.oragenics.com
| Oragenics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of products and technologies associated with oral health, antibiotics, and other general health benefits. The company develops Probiora3, an oral probiotics technology that employs three natural strains of beneficial bacteria, which promote oral health; LPT3-04 for weight loss; and DPOLT or differentially protected orthogonal lantionine technology, which is a solid or liquid phase peptide synthesis platform technology that has various applications for the manufacture of commercially important bioactive peptides. It is also developing Mutacin 1140, an antibiotic with antimicrobial activity against gram-positive bacteria, including methicillin-resistant and vancomycin-resistant Staphylococcus aureus; Proteomic-based In-Vivo Induced Antigen Technology (PIVIAT) and Proteomic-based Change Mediated Antigen Technology (PCMAT) diagnostic platforms that enable the identification of novel and potentially important gene targets associated with the natural onset and progression of infections, cancers, and other diseases in humans and other living organisms, including plants; and SMaRT Replacement Therapy, which is a painless topical treatment for protection against tooth decay. The company primarily operates in the United States and Mexico. It was formerly known as Oragen, Inc. The company was founded in 1996 and is based in Alachua, Florida. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David B. Hirsch , 40
Chief Exec. Officer, Pres, Director and Member of Audit Committee |
$
144.00K |
$
0 | Dr. Jeffrey D. Hillman DMD, Ph.D., 60
Co-Founder, Chief Scientific Officer, Director and Member of Audit Committee |
$
180.00K |
$
0 | Dr. Robert T. Zahradnik Ph.D., 64
Director of Operations |
$
80.00K |
$
0 | Ms. Dorothy Jean Delfino , 63
Consultant |
$
61.00K |
$
0 | Mr. Stanley B. Stein J.D., 56
Advisor |
$
220.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
Profile
